NCT06254495 2026-03-16A Safety Study of PF-08046044/SGN-35C in Adults With Advanced CancersSeagen Inc.Phase 1 Active not recruiting57 enrolled
NCT05160922 2025-09-03Crizotinib Continuation Clinical StudyPfizerPhase 4 Active not recruiting27 enrolled